Senior Leadership

高层领导

• 批准号: 8710379
• 负责人: ROBERT B. DIASIO
• 金额: $ 3.13万
• 依托单位: MAYO CLINIC ROCHESTER
• 依托单位国家: 美国
• 财政年份: 2013
• 资助国家: 美国
• 起止时间: 2013-09-30 至 2014-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8710379
• 关键词: Appointment; Arizona; Basic Science; Cancer Center; Cancer Center Support Grant; Clinic; Clinical; Clinical Research; Comprehensive Cancer Center; Florida; Grant; Hematologic Neoplasms; Leadership; Mayo Clinic Cancer Center; Population Sciences; Positioning Attribute; Recruitment Activity; Research; Research Activity; Site; Training and Education; Translational Research; cancer research center director; programs

Mayo Clinic Cancer Center (MCCC) Senior Leadership encompasses the Director, Deputy Director Clinical Affairs, Deputy Director MCCC Arizona, Deputy Director MCCC Florida, and 5 Associate Directors. There have been a number of changes since the last renewal. As part of a planned succession following the successful 2003 CCSG competitive renewal, Dr. Robert Diasio was recruited as Cancer Center Director in a national search initiated in mid 2005 culminating with his appointment effective September 1, 2006. Dr. Charles Erlichman, previously an MCCC Associate Director, was appointed Deputy Director for Clinical Affairs in late 2004. In his position as Deputy Director for Clinical Affairs, he has primary responsibility for overseeing and implementing integration of the Cancer Center's clinical research activities across all three sites. Also in late 2004, Dr. Robert Smallridge was formally appointed as Deputy Director for MCCC Florida; having previously been the acting Deputy Director. Dr. Rafael Fonseca, co-program leader of the Hematologic Malignancies Program, was appointed as Deputy Director for MCCC Arizona in July 2006 succeeding Dr. Laurence J. Miller who stepped down to focus on his responsibilities as Associate Dean for Research at Mayo Clinic and Director for Research at Mayo Clinic Arizona. Senior Leadership otherwise remains unchanged at the level of the Associate Directors with Dr. Ed Leof continuing as Associate Director for Basic Sciences, Dr. Gloria Petersen as Associate Director for Population Sciences, Dr. Robert Jenkins as Associate Director for Translational Research, Mr. Michael Pfenning as Associate Director for Administration and Dr. Lynn Hartmann as Associate Director for Education and Training. SENIOR/

梅奥诊所癌症中心 (MCCC) 的高级领导层包括主任、临床副主任 事务，副主任 MCCC 亚利桑那州，副主任 MCCC 佛罗里达州，以及 5 名副主任。 自上次更新以来发生了许多变化。作为以下计划继承的一部分 2003 年 CCSG 竞争性更新成功，Robert Diasio 博士被聘为癌症中心 2005 年中期开始的全国性搜寻主任最终于 9 月 1 日生效， 2006. Charles Erlichman 博士（前 MCCC 副主任）被任命为副主任 2004 年底开始临床事务。在担任临床事务副主任期间，他主要负责 负责监督和实施癌症中心临床研究活动的整合 跨越所有三个站点。同样在 2004 年底，Robert Smallridge 博士被正式任命为副主任 MCCC 佛罗里达州；此前曾担任代理副主任。 Rafael Fonseca 博士，联合项目 血液恶性肿瘤项目的负责人，于 2017 年被任命为 MCCC Arizona 的副主任 2006 年 7 月，接替 Laurence J. Miller 博士，后者辞职并专注于其职责 梅奥诊所研究副院长和亚利桑那州梅奥诊所研究主任。 高级领导层在其他方面保持不变，为 Ed Leof 博士的副董事级别 继续担任基础科学部副主任，Gloria Petersen 博士担任基础科学部副主任 人口科学，罗伯特·詹金斯博士，转化研究副主任，迈克尔先生 Pfenning 担任行政副主任，Lynn Hartmann 博士担任副主任 教育和培训。 高级的/